Raymond James Financial, Inc. (RJF) Stock Price Today
Aura AI Summary
Key Stats
- $32.88BMarket Cap
- -Volume
- FinancialsSector
- $176.4352W High
- $140.8952W Low
- -Typical Hold Time
- -Enterprise Value
- 1.28%Div Yield
- -Trading Activity
Track Raymond James Financial, Inc. (RJF) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Raymond James Financial, Inc. has traded between a low of $140.89 and a high of $176.43, highlighting its annual price range. Buy and sell Raymond James Financial, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Most Recent News
Document AI market to nearly double to $27.62B by 2030, driven by AI and automation in regulated industries.
The Document AI market is forecasted to grow from $14.66 billion in 2025 to $27.62 billion by 2030, at a CAGR of 13.5%. This growth is fueled by organizations adopting AI technologies like intelligent document processing, generative AI, and workflow ...

AI in orthopedic surgery market to hit $0.87B by 2030 with 27.2% CAGR, driven by tech advances and rising musculoskeletal disorders
The AI in orthopedic surgery market is projected to grow from $0.26 billion in 2025 to $0.87 billion by 2030, at a CAGR of 27.2%. Growth is fueled by increased orthopedic surgeries, innovations in medical imaging, adoption of minimally invasive techn...

Generative AI in drug discovery market to reach $0.86B by 2030, growing at 27% CAGR driven by faster drug development and AI advances
The generative AI market in drug discovery is expanding rapidly, expected to grow from $0.33 billion in 2026 to $0.86 billion by 2030 with a 27% CAGR. Growth is fueled by rising drug development costs, advances in AI technologies like deep learning, ...
